Mechanistically, ZMIZ2 promotes HCC cell proliferation, migration, and invasion by activating the Wnt/β-catenin signaling pathway through the upregulation of LEF1 (Fig. 9). Here, ZMIZ2 is linked to hepatocellular carcinoma.